|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| GROSS PROFIT | |||||
| Selling, general and administrative expense | |||||
| Engineering and product development expense | |||||
| Operating (loss) income | |||||
| Other income (expense): | |||||
| Gain on sale of asset | |||||
| Change in fair value of derivative component of convertible debt | |||||
| Interest income | |||||
| Interest expense | |||||
| Net (loss) income before income taxes | |||||
| Provision for income tax (expense) benefit | |||||
| NET (LOSS) INCOME | |||||
| (Loss) Income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used in computing net (loss) income per share: | |||||
| Weighted average basic shares outstanding (in shares) | |||||
| Weighted average diluted shares outstanding (in shares) |
Loading...